• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以同样方式对待莱克:对使用纠缠来阐释顺势疗法的批评的回应

Treating Leick with like: response to criticisms of the use of entanglement to illustrate homeopathy.

作者信息

Milgrom Lionel R

机构信息

Homeopathy Research Institute, 63 Vale Road, London N4 1PP, UK.

出版信息

Homeopathy. 2008 Apr;97(2):96-9. doi: 10.1016/j.homp.2008.02.002.

DOI:10.1016/j.homp.2008.02.002
PMID:18439971
Abstract

In criticising papers which recently appeared in Homeopathy, Leick claims that no double blind randomised clinical trials (DBRCTs) show that homeopathy is efficacious, and that specific effects of substances diluted beyond Avogadro's limit are implausible. He states that generalised entanglement models should be able to improve the design of experiments to test ultra-high dilutions, and disparages the authors' understandings of quantum physics. The paper responds to those criticisms. Several DBRCTs have shown that homeopathy has effects which are not due to placebo and these are now supported by preclinical work. This area of theory is in its infancy and it is unreasonable to expect it to have generated experiments at this stage. The authors have used accepted interpretations of quantum theory: Leick's view is coloured by skepticism concerning homeopathy.

摘要

在批评近期发表于《顺势疗法》的论文时,莱克声称没有双盲随机临床试验(DBRCTs)表明顺势疗法有效,并且稀释超过阿伏伽德罗极限的物质的特定效应是不合理的。他指出广义纠缠模型应该能够改进测试超高稀释度的实验设计,并贬低了作者对量子物理学的理解。本文对这些批评做出回应。多项双盲随机临床试验表明顺势疗法具有并非由安慰剂导致的效果,并且这些现在得到了临床前研究的支持。该理论领域尚处于起步阶段,期望它在现阶段已经产生实验是不合理的。作者们采用了被广泛接受的量子理论解释:莱克的观点因对顺势疗法的怀疑而带有偏见。

相似文献

1
Treating Leick with like: response to criticisms of the use of entanglement to illustrate homeopathy.以同样方式对待莱克:对使用纠缠来阐释顺势疗法的批评的回应
Homeopathy. 2008 Apr;97(2):96-9. doi: 10.1016/j.homp.2008.02.002.
2
Modern or post-modern? Local or non-local? A response to Leick.
Homeopathy. 2008 Apr;97(2):100-2. doi: 10.1016/j.homp.2008.02.010.
3
Comment on: "Conspicuous by its absence: the Memory of Water, macro-entanglement, and the possibility of homeopathy" and "The nature of the active ingredient in ultramolecular dilutions".
Homeopathy. 2008 Jan;97(1):50-1. doi: 10.1016/j.homp.2007.11.007.
4
Conspicuous by its absence: the Memory of Water, macro-entanglement, and the possibility of homeopathy.
Homeopathy. 2007 Jul;96(3):209-19. doi: 10.1016/j.homp.2007.05.002.
5
Straw men and black swans: the philosophy of contemporary science.
Homeopathy. 2008 Jan;97(1):47-8; author reply 48-50. doi: 10.1016/j.homp.2007.11.008.
6
Are randomized controlled trials (RCTs) redundant for testing the efficacy of homeopathy? A critique of RCT methodology based on entanglement theory.随机对照试验(RCTs)对于测试顺势疗法的疗效是否多余?基于纠缠理论对RCT方法的批判。
J Altern Complement Med. 2005 Oct;11(5):831-8. doi: 10.1089/acm.2005.11.831.
7
The nature of the active ingredient in ultramolecular dilutions.超分子稀释液中活性成分的性质。
Homeopathy. 2007 Jul;96(3):220-6. doi: 10.1016/j.homp.2007.05.005.
8
What is the therapeutically active ingredient of homeopathic potencies?顺势疗法药力的治疗活性成分是什么?
Homeopathy. 2003 Jul;92(3):145-51. doi: 10.1016/s1475-4916(03)00037-7.
9
Patient-practitioner-remedy (PPR) entanglement. Part 5. Can homeopathic remedy reactions be outcomes of PPR entanglement?患者-从业者-疗法(PPR)纠缠。第5部分。顺势疗法的疗法反应能否成为PPR纠缠的结果?
Homeopathy. 2004 Apr;93(2):94-8. doi: 10.1016/j.homp.2004.01.002.
10
Entanglement, knowledge, and their possible effects on the outcomes of blinded trials of homeopathic provings.纠缠、知识及其对顺势疗法验证双盲试验结果的可能影响。
J Altern Complement Med. 2006 Apr;12(3):271-9. doi: 10.1089/acm.2006.12.271.

引用本文的文献

1
Testing the nanoparticle-allostatic cross-adaptation-sensitization model for homeopathic remedy effects.测试顺势疗法药物效果的纳米颗粒 - 异态交叉适应 - 致敏模型。
Homeopathy. 2013 Jan;102(1):66-81. doi: 10.1016/j.homp.2012.10.005.